BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17125254)

  • 1. Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: potential for development of tumor-selective N-oxides.
    Pors K; Shnyder SD; Teesdale-Spittle PH; Hartley JA; Zloh M; Searcey M; Patterson LH
    J Med Chem; 2006 Nov; 49(24):7013-23. PubMed ID: 17125254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells.
    Pors K; Paniwnyk Z; Ruparelia KC; Teesdale-Spittle PH; Hartley JA; Kelland LR; Patterson LH
    J Med Chem; 2004 Mar; 47(7):1856-9. PubMed ID: 15027879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
    Atwell GJ; Fan JY; Tan K; Denny WA
    J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin dimers: polyfunctional cross-linkers of DNA.
    Paz MM; Kumar GS; Glover M; Waring MJ; Tomasz M
    J Med Chem; 2004 Jun; 47(12):3308-19. PubMed ID: 15163210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes.
    Kakadiya R; Dong H; Lee PC; Kapuriya N; Zhang X; Chou TC; Lee TC; Kapuriya K; Shah A; Su TL
    Bioorg Med Chem; 2009 Aug; 17(15):5614-26. PubMed ID: 19576785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new bifunctional compounds which selectively alkylate guanines in DNA.
    Henderson ND; Lacy SM; O'Hare CC; Hartley JA; McClean S; Wakelin LP; Kelland LR; Robins DJ
    Anticancer Drug Des; 1998 Oct; 13(7):749-68. PubMed ID: 9807160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
    Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
    Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of nonsymmetrical 1,4-disubstituted anthraquinones that are potently active against cisplatin-resistant ovarian cancer cells.
    Pors K; Plumb JA; Brown R; Teesdale-Spittle P; Searcey M; Smith PJ; Patterson LH
    J Med Chem; 2005 Oct; 48(21):6690-5. PubMed ID: 16220985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity.
    Fourie J; Guziec F; Guziec L; Monterrosa C; Fiterman DJ; Begleiter A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):191-203. PubMed ID: 14614574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsymmetrical DNA cross-linking agents: combination of the CBI and PBD pharmacophores.
    Tercel M; Stribbling SM; Sheppard H; Siim BG; Wu K; Pullen SM; Botting KJ; Wilson WR; Denny WA
    J Med Chem; 2003 May; 46(11):2132-51. PubMed ID: 12747786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: discovery of an unusual structure-activity relationship.
    Rachid Z; Brahimi F; Qiu Q; Williams C; Hartley JM; Hartley JA; Jean-Claude BJ
    J Med Chem; 2007 May; 50(11):2605-8. PubMed ID: 17472358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of new homochiral bispyrrolidines as potential DNA cross-linking antitumour agents.
    Anderson FM; O'Hare CC; Hartley JA; Robins DJ
    Anticancer Drug Des; 2000 Apr; 15(2):119-26. PubMed ID: 10901299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linker length modulates DNA cross-linking reactivity and cytotoxic potency of C8/C8' ether-linked C2-exo-unsaturated pyrrolo[2,1-c][1,4]benzodiazepine (PBD) dimers.
    Gregson SJ; Howard PW; Gullick DR; Hamaguchi A; Corcoran KE; Brooks NA; Hartley JA; Jenkins TC; Patel S; Guille MJ; Thurston DE
    J Med Chem; 2004 Feb; 47(5):1161-74. PubMed ID: 14971896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BINOL-amino acid conjugates as triggerable carriers of DNA-targeted potent photocytotoxic agents.
    Doria F; Richter SN; Nadai M; Colloredo-Mels S; Mella M; Palumbo M; Freccero M
    J Med Chem; 2007 Dec; 50(26):6570-9. PubMed ID: 18047263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
    Henderson ND; Plumb JA; Robins DJ; Workman P
    Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
    Kim MY; Na Y; Vankayalapati H; Gleason-Guzman M; Hurley LH
    J Med Chem; 2003 Jul; 46(14):2958-72. PubMed ID: 12825936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking and sequence-specific alkylation of DNA by aziridinylquinones. 3. Effects of alkyl substituents.
    Hargreaves RH; O'Hare CC; Hartley JA; Ross D; Butler J
    J Med Chem; 1999 Jun; 42(12):2245-50. PubMed ID: 10377230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-N,7'-N'-(1",2"-Dithianyl-3",6"-dimethylenyl)bismitomycin C: synthesis and nucleophilic activation of a dimeric mitomycin.
    Lee SH; Kohn H
    Org Biomol Chem; 2005 Feb; 3(3):471-82. PubMed ID: 15678185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
    Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
    Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of a novel DNA-DNA interstrand adenine-guanine cross-linking agent.
    Zhou Q; Duan W; Simmons D; Shayo Y; Raymond MA; Dorr RT; Hurley LH
    J Am Chem Soc; 2001 May; 123(20):4865-6. PubMed ID: 11457309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.